Professional Documents
Culture Documents
03 - 2021-01-26 CT Assignment
03 - 2021-01-26 CT Assignment
Assignment 1
Pfizer Inc. (NYSE: PFE) 2019 2018 *in millions USD
A. Total Liabilities 104,042 95,664 *
B. Total Equity 63,447 63,758 *
C. Sales 51,750 53,647 *
D. COGS 10,219 11,248 *
E. Net Income 16,273 11,153 *
F. Cash & Cash Equivalents 1,305 1,139 *
G. Short-term investments 8,525 17,694 *
H. Current Liabilities 37,304 31,858 *
I. Accounts Receivable 8,724 8,025 *
J. Market Value per Share 37.31 43.65 At closing Dec 31 of fiscal year
K. EPS 2.87 1.87
RATIOS:
Debt to Equity A/B 1.639825 1.500423
Gross Margin C-D 41,531 42,399 *
Return on Equity E/B 0.256482 0.174927
Quick Ratio (F+G+I)/H 0.497373 0.843054
Price to Earnings ratio J/K 13 23.34225